Company: INKT
Filing Date: 2025-11-14
Form Type: 10-Q
Source: 0001193125-25-282905
Chunk: 0

Company: MiNK Therapeutics, Inc.
Filing Date: 2025-11-14
Form: 10-Q
Item: Item 1
Chunk 0
---
MINK THERAPEUTICS, INC. AND SUBSIDIARIES 

CONDENSED CONSOLIDATED BALANCE SHEETS 

(Unaudited) 

     September 30,2025

     December 31,2024

     ASSETS

     Cash and cash equivalents
      
     $
     14,281,212

     $
     4,577,040

     Prepaid expenses

     253,077

     246,600

     Other current assets

     32

     164,244

     Total current assets

     14,534,321

     4,987,884

     Equipment, net of accumulated depreciation of $573,603 and $524,639 at  September 30, 2025 and December 31, 2024, respectively

     429,344

     732,929

     Total assets
      
     $
     14,963,665

     $
     5,720,813

     LIABILITIES AND STOCKHOLDERS’ DEFICIT

     Accounts payable
      
     $
     3,693,115

     $
     2,728,212

     Accrued liabilities

     1,256,965

     1,873,561

     Related party note

     5,725,267

     —

     Other current liabilities

     2,758,207

     2,357,903

     Total current liabilities

     13,433,554

     6,959,676

     Related party note

     —

     4,924,612

     Due to related parties

     15,043,093

     13,422,407

     Commitments and contingencies

     STOCKHOLDERS’ DEFICIT

     Common stock, par value $0.00001 per share; 150,000,000 shares   authorized; 4,600,585 and 3,963,045 shares issued at   September 30, 2025 and December 31, 2024, respectively

     46

     40

     Additional paid-in capital

     141,252,978

     125,227,389

     Accumulated other comprehensive loss

     (692,114
     )

     (631,576
     )

     Accumulated deficit

     (154,